Cargando…

Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis

Background: The effectiveness of antibiotics for the treatment of severe bacterial infections in newborns in resource-limited settings has been determined by empirical evidence. However, such an approach does not warrant optimal exposure to antibiotic agents, which are known to show different dispos...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Agate, S., Musuamba, F. Tshinanu, Jacqz-Aigrain, E., Della Pasqua, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982486/ https://www.ncbi.nlm.nih.gov/pubmed/33762945 http://dx.doi.org/10.3389/fphar.2021.624662

Ejemplares similares

Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible
por: D’Agate, Salvatore, et al.
Publicado: (2020)

Simplified Dosing of Gentamicin for Treatment of Sepsis in Bangladeshi Neonates
por: Hossain, M. Monir, et al.
Publicado: (2009)

Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients
por: Romano, Federico, et al.
Publicado: (2021)

Use and safety of azithromycin in neonates: a systematic review
por: Smith, Coral, et al.
Publicado: (2015)

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
por: Hill, Louise F., et al.
Publicado: (2020)

Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK
por: Zazo, Hinojal, et al.
Publicado: (2022)

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Extended-interval Dosing of Gentamicin for Treatment of Neonatal Sepsis in Developed and Developing Countries
por: Darmstadt, Gary L., et al.
Publicado: (2008)

Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework
por: Skottheim Rusten, Ine, et al.
Publicado: (2021)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Exposure to an Extended-Interval, High-Dose Gentamicin Regimen in the Neonatal Period Is Not Associated With Long-Term Nephrotoxicity
por: Rypdal, Veronika, et al.
Publicado: (2021)

Is fat‐free mass‐based gentamicin dosing regimen preferable than whole‐body weight in neonates?
por: Sridharan, Kannan, et al.
Publicado: (2023)

"Random" gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens
por: Boyle, Elaine M, et al.
Publicado: (2006)

Evaluation of Dosing Guidelines for Gentamicin in Neonates and Children
por: Hollander, Esther M., et al.
Publicado: (2023)

1314. Neonatal Serum Gentamicin Concentrations following Maternal Once-daily Gentamicin Dosing
por: Wilson, Genene A, et al.
Publicado: (2020)

Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach
por: Kaguelidou, Florentia, et al.
Publicado: (2016)

Clinical trials in neonates: How to optimise informed consent and decision making? A European Delphi survey of parent representatives and clinicians
por: Neyro, Virginia, et al.
Publicado: (2018)

Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
por: Shang, Zhen-Hai, et al.
Publicado: (2022)

Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry
por: Desselas, Emilie, et al.
Publicado: (2017)

European survey on the use of prophylactic fluconazole in neonatal intensive care units
por: Kaguelidou, Florentia, et al.
Publicado: (2011)

Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis
por: Gastine, Silke, et al.
Publicado: (2021)

Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
por: Aurich, Beate, et al.
Publicado: (2021)

Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis
por: González-Vázquez, Patricia, et al.
Publicado: (2017)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

405 Risk of gentamicin vestibulotoxicity with different dosing regimens: a retrospective cohort study
por: Leis, Jerome, et al.
Publicado: (2014)

Model‐based meta‐analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms
por: D'Agate, Salvatore, et al.
Publicado: (2020)

Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH
por: D’Agate, Salvatore, et al.
Publicado: (2019)

Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
por: D’Agate, Salvatore, et al.
Publicado: (2020)

Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or severe symptoms
por: D'Agate, Salvatore, et al.
Publicado: (2021)

Informed consent for neonatal trials: practical points to consider and a check list
por: Aurich, Beate, et al.
Publicado: (2020)

In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products
por: Viceconti, Marco, et al.
Publicado: (2021)

Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
por: Chen, Xiao, et al.
Publicado: (2021)

Latamoxef for Neonates With Early-Onset Neonatal Sepsis: A Study Protocol for a Randomized Controlled Trial
por: Qi, Hui, et al.
Publicado: (2021)

Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey
por: Pansieri, Claudia, et al.
Publicado: (2014)

Edible Bird Nest Protects the Kidney From Gentamicin Induced Acute Tubular Necrosis
por: Lim, Christopher T S., et al.
Publicado: (2021)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints
por: Bhavnani, S. M., et al.
Publicado: (2022)

Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder
por: Jin, Zi-bin, et al.
Publicado: (2022)

Optimized Dosing Regimens of Meropenem in Septic Children Receiving Extracorporeal Life Support
por: Wang, Yixue, et al.
Publicado: (2021)

Flat dose regimen of toripalimab based on model-informed drug development approach
por: Li, Lili, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vgma3vmtfj3prnq79lbi79p603